Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CMTG NYSEAMERICAN:LPA NASDAQ:REAX NASDAQ:SMMT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCMTGClaros Mortgage Trust$2.53+3.9%$2.42$2.05▼$3.99$340.73M1.14456,386 shs384,161 shsLPALogistic Properties of the Americas$2.85-1.4%$3.29$2.04▼$7.64$91.38M5.2817,246 shs12,941 shsREAXReal Brokerage$1.64-2.4%$2.12$1.58▼$5.41$358.68M0.743.35 million shs2.50 million shsSMMTSummit Therapeutics$13.05-8.7%$18.77$12.55▼$30.98$11.09B-1.325.22 million shs8.61 million shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCMTGClaros Mortgage Trust+3.84%-0.81%+0.41%+1.25%-18.56%LPALogistic Properties of the Americas+1.40%-4.93%-15.00%+11.58%-60.68%REAXReal Brokerage-0.59%-2.33%-17.65%-30.00%-60.38%SMMTSummit Therapeutics+1.28%-3.84%-20.96%-11.08%-33.72%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCMTGClaros Mortgage Trust$2.53+3.9%$2.42$2.05▼$3.99$340.73M1.14456,386 shs384,161 shsLPALogistic Properties of the Americas$2.85-1.4%$3.29$2.04▼$7.64$91.38M5.2817,246 shs12,941 shsREAXReal Brokerage$1.64-2.4%$2.12$1.58▼$5.41$358.68M0.743.35 million shs2.50 million shsSMMTSummit Therapeutics$13.05-8.7%$18.77$12.55▼$30.98$11.09B-1.325.22 million shs8.61 million shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCMTGClaros Mortgage Trust+3.84%-0.81%+0.41%+1.25%-18.56%LPALogistic Properties of the Americas+1.40%-4.93%-15.00%+11.58%-60.68%REAXReal Brokerage-0.59%-2.33%-17.65%-30.00%-60.38%SMMTSummit Therapeutics+1.28%-3.84%-20.96%-11.08%-33.72%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCMTGClaros Mortgage Trust 1.50Reduce$2.9215.51% UpsideLPALogistic Properties of the Americas 2.00Hold$7.50163.16% UpsideREAXReal Brokerage 2.88Moderate Buy$5.69246.80% UpsideSMMTSummit Therapeutics 2.39Hold$26.0599.65% UpsideCurrent Analyst Ratings BreakdownLatest LPA, SMMT, CMTG, and REAX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/1/2026SMMTSummit Therapeutics KeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight5/26/2026CMTGClaros Mortgage Trust Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/26/2026REAXReal Brokerage Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/24/2026LPALogistic Properties of the AmericasBtg PactualSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$7.505/22/2026SMMTSummit Therapeutics Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight5/22/2026SMMTSummit Therapeutics HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Neutral5/21/2026SMMTSummit Therapeutics Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageUnderperform$7.705/21/2026SMMTSummit Therapeutics Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell5/13/2026CMTGClaros Mortgage Trust Keefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetUnderperform$2.50 ➝ $2.255/13/2026LPALogistic Properties of the Americas Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold5/11/2026REAXReal Brokerage Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)(Data available from 6/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCMTGClaros Mortgage Trust$187.83M1.88N/AN/A$10.93 per share0.23LPALogistic Properties of the Americas$50.13M1.80$0.36 per share7.94$10.27 per share0.28REAXReal Brokerage$1.97B0.18N/AN/A$0.24 per share6.83SMMTSummit TherapeuticsN/AN/AN/AN/A$0.85 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCMTGClaros Mortgage Trust-$489.07M-$3.32N/AN/AN/A-267.14%-19.34%-6.27%8/5/2026 (Estimated)LPALogistic Properties of the Americas$10.50MN/A28.503.43N/A6.31%1.08%0.49%8/12/2026 (Estimated)REAXReal Brokerage-$8.10M-$0.03N/A164.00N/A-0.32%-11.37%-4.32%8/6/2026 (Estimated)SMMTSummit Therapeutics-$1.08B-$1.60N/AN/AN/AN/A-291.24%-243.07%8/10/2026 (Estimated)Latest LPA, SMMT, CMTG, and REAX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026LPALogistic Properties of the AmericasN/A-$0.25N/A-$0.25N/A$14.40 million5/7/2026Q1 2026REAXReal Brokerage-$0.03-$0.02+$0.01-$0.02$474.84 million$465.55 million5/6/2026Q1 2026CMTGClaros Mortgage Trust-$0.2384-$0.52-$0.2816-$0.39$36.94 million$29.52 million5/1/2026Q1 2026SMMTSummit Therapeutics-$0.2692-$0.24+$0.0292-$0.24$0.05 millionN/A3/31/2026Q4 2025REAXReal BrokerageN/A-$0.02N/A-$0.02N/A$465.55 million3/18/2026Q4 2025LPALogistic Properties of the AmericasN/A$0.1950N/A$0.1950N/A$13.71 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCMTGClaros Mortgage TrustN/AN/AN/AN/AN/ALPALogistic Properties of the AmericasN/AN/AN/AN/AN/AREAXReal BrokerageN/AN/AN/AN/AN/ASMMTSummit TherapeuticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCMTGClaros Mortgage Trust1.5321.4421.44LPALogistic Properties of the Americas0.931.571.57REAXReal BrokerageN/A2.722.72SMMTSummit TherapeuticsN/A7.417.41Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCMTGClaros Mortgage Trust89.53%LPALogistic Properties of the Americas42.71%REAXReal Brokerage53.28%SMMTSummit Therapeutics4.61%Insider OwnershipCompanyInsider OwnershipCMTGClaros Mortgage Trust1.80%LPALogistic Properties of the Americas32.00%REAXReal Brokerage38.21%SMMTSummit Therapeutics83.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCMTGClaros Mortgage TrustN/A140.22 million137.70 millionOptionableLPALogistic Properties of the Americas3031.62 million21.50 millionN/AREAXReal Brokerage60213.50 million131.92 millionOptionableSMMTSummit Therapeutics110776.16 million128.07 millionOptionableLPA, SMMT, CMTG, and REAX HeadlinesRecent News About These CompaniesWhy is SMMT stock tumbling today?June 10 at 12:20 PM | msn.comNorges Bank Takes $24.03 Million Position in Summit Therapeutics PLC $SMMTJune 10 at 4:50 AM | marketbeat.comSummit Therapeutics Announces Proposed Public Offering of Common StockJune 9 at 5:04 PM | businesswire.comSummit Therapeutics Inc. (SMMT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptJune 8 at 4:04 PM | seekingalpha.comTD Asset Management Inc Increases Stock Position in Summit Therapeutics PLC $SMMTJune 8 at 6:44 AM | marketbeat.comMizuho Strategist: Healthcare Is Now a Value Sector as Pharma Stocks Underperform TechJune 7 at 9:30 AM | 247wallst.comInsider Buying: Summit Therapeutics (NASDAQ:SMMT) CEO Purchases $1,460,000.00 in StockJune 7 at 4:35 AM | americanbankingnews.comInsider Buying: Summit Therapeutics (NASDAQ:SMMT) CEO Acquires $1,460,000.00 in StockJune 7 at 4:35 AM | americanbankingnews.comThe Era of the One-Size-Fits-All Cancer Drug Is EndingJune 6, 2026 | wsj.comSummit Therapeutics (SMMT) Reveals Phase II AK112-206 Trial DataJune 5, 2026 | finance.yahoo.comSummit Therapeutics (NASDAQ:SMMT) CFO Manmeet Singh Soni Buys 50,000 SharesJune 5, 2026 | insidertrades.comSummit Therapeutics to Participate in the 47th Annual Goldman Sachs Global Healthcare ConferenceJune 4, 2026 | businesswire.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Summit Therapeutics (SMMT), Oculis Holding (OCS) and Cogent Biosciences (COGT)June 4, 2026 | theglobeandmail.comAssessing Summit Therapeutics (SMMT) Valuation After A Mixed Share Price And Long Term Return ProfileJune 4, 2026 | finance.yahoo.comAll You Need to Know About Summit Therapeutics (SMMT) Rating Upgrade to BuyJune 4, 2026 | zacks.comSummit Therapeutics Inc. (SMMT) Discusses Plenary Session Updates and Recent Clinical Data Following Major Oncology Congress - SlideshowJune 3, 2026 | seekingalpha.comCantor Fitzgerald Maintains Overweight Rating on Summit Therapeutics (SMMT) Amid Mixed Clinical DevelopmentsJune 2, 2026 | insidermonkey.comSummit Therapeutics (SMMT) Sheds 10.4%, This Analyst is PessimisticJune 2, 2026 | insidermonkey.comSummit Therapeutics Inc. (SMMT) Discusses Plenary Session Updates and Recent Clinical Data Following Major Oncology Congress TranscriptJune 1, 2026 | seekingalpha.comWall Street Analysts Think Summit Therapeutics (SMMT) Could Surge 67.1%: Read This Before Placing a BetJune 1, 2026 | zacks.comSummit rises after lung cancer drug trial shows 15% higher survival rate than rival'sJune 1, 2026 | reuters.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeLPA, SMMT, CMTG, and REAX Company DescriptionsClaros Mortgage Trust NYSE:CMTG$2.52 +0.10 (+3.91%) Closing price 03:59 PM EasternExtended Trading$2.51 -0.02 (-0.59%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Claros Mortgage Trust, Inc. operates as a real estate investment trust. It focuses on originating senior and subordinate loans on transitional commercial real estate assets in the United States. The company has elected to be taxed as a real estate investment trust. As a result, it would not be subject to corporate income tax on that portion of its net income that is distributed to shareholders. The company was incorporated in 2015 and is headquartered in New York, New York.Logistic Properties of the Americas NYSEAMERICAN:LPA$2.85 -0.04 (-1.38%) Closing price 04:10 PM EasternExtended Trading$2.84 0.00 (-0.18%) As of 06:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Logistic Properties of the Americas develops, builds and operates logistic real estate properties. It operates through the following geographical segments: Colombia, Peru, and Costa Rica. The company is headquartered in Miami, FL.Real Brokerage NASDAQ:REAX$1.64 -0.04 (-2.38%) Closing price 04:00 PM EasternExtended Trading$1.61 -0.03 (-1.83%) As of 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.The Real Brokerage Inc., together with its subsidiaries, operates as a real estate technology company in the United States and Canada. It operates in three segments: North American Brokerage, Real Title, and One Real Mortgage. It offers brokerage, title, and mortgage broker services. The company is based in Miami, Florida.Summit Therapeutics NASDAQ:SMMT$13.05 -1.24 (-8.68%) Closing price 04:00 PM EasternExtended Trading$13.07 +0.02 (+0.15%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the United States, and the United Kingdom. The company's lead development candidate is Ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis; and anti-infectives portfolio includes SMT-738, a novel class of precision antibiotics for the treatment of multidrug resistant infections, which primarily includes carbapenem-resistant Enterobacteriaceae infections. It has a collaboration and license agreement with Akeso, Inc. and its affiliates to develop and commercialize ivonescimab, as well as strategic collaboration with The University of Texas MD Anderson Cancer Center for the purpose of accelerating the development of ivonescimab. The company was founded in 2003 and is headquartered in Miami, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Biggest Opportunity From SpaceX’s IPO May Surprise You Chewy’s Growth Engine Is Stronger Than the Market Thinks Everpure: AI Storage Uncertainty Overshadows Breakneck Growth This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason FuelCell Energy Just Got a Wake-Up Call From Wall Street Intel Is the Market's Most Mispriced AI Hedge Palantir's AIPCon Shows Why Customers Are Fueling the Bull Case Uranium Energy Corp Melts Down—Nuclear Opportunity at Hand Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
